Relay Therapeutics Inc (RLAY)
NASDAQ
Quarter End | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |||
総売上 | 10.8M | 1.23M | 2.27M | 26.4M | 2.07M | 11.84M | 11.37M | 0 |
営業利益 | -72.85M | -101.18M | -106.05M | -73.58M | -92.2M | -90.36M | -100.76M | -96.37M |
税引前収入 | -67.5M | -94.24M | -98.51M | -65.73M | -83.5M | -81.39M | -92.21M | -88.11M |
純利益 | -67.5M | -94.24M | -98.51M | -65.73M | -83.5M | -81.39M | -92.21M | -88.11M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -72.87M | -101.18M | -106.06M | -73.58M | -92.2M | -90.34M | -100.76M | -96.38M |
EBITDA | -71.69M | -99.98M | -104.72M | -72.21M | -90.82M | -88.97M | -99.39M | -95M |
年末 2023年12月31日 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 0 | 0 | 82.65M | 3.03M | 13.06M | 31.97M |
営業利益 | -49.89M | -84.05M | -55.8M | -364.7M | -299.28M | -373M |
税引前収入 | -48.79M | -75.31M | -52.41M | -363.87M | -290.51M | -341.97M |
純利益 | -48.79M | -75.31M | -230.2M | -363.87M | -290.51M | -341.97M |
優先配当 | 0 | 0 | -177.79M | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -4.583 | -5.253 | -2.56 | -4.043 | -2.399 | -2.774 |
EBIT | -49.9M | -84.11M | -55.81M | -364.7M | -299.3M | -373.02M |
EBITDA | -47.74M | -81.2M | -52.25M | -360.77M | -295.15M | -367.73M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約